Effect of Surfactant Coating on Brain Targeting Polymeric Nanoparticles; a Review

被引:22
作者
Chacko, B. J. [1 ]
Palanisamy, S. [2 ]
Gowrishankar, N. L. [1 ]
Honeypriya, J. [3 ]
Sumathy, A. [1 ]
机构
[1] Prime Coll Pharm, Dept Pharm, Palakkad 678551, India
[2] Int Med Univ, Sch Pharm, Kuala Lumpur 57000, Malaysia
[3] IIT B, Dept Chem Engn, Bombay 400076, Maharashtra, India
关键词
Blood-brain barrier; polysorbate; 80; brain targeting; nanoparticles; surfactant; polymers; 80-COATED POLYBUTYLCYANOACRYLATE NANOPARTICLES; MODIFIED PLGA NANOPARTICLES; ORAL-DRUG DELIVERY; IN-VIVO; ALZHEIMERS-DISEASE; POLY(N-BUTYLCYANOACRYLATE) NANOPARTICLES; CYANOACRYLATE) NANOPARTICLES; SILICA NANOPARTICLES; PARTICULATE MATTER; BARRIER;
D O I
10.4172/pharmaceutical-sciences.1000348
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Targeting of drugs to brain is one of the most challenging issues for pharmaceutical research as blood-brain barrier acts as an insurmountable obstacle for the passage of systemically delivered therapeutics and the brain extracellular matrix attributes to poor distribution of locally delivered drugs. Amongst various invasive or non-invasive methods to warrant blood-brain barrier, nanoparticle is one of promising ways to administer central nervous system drugs. The concept of nanoparticle-based drug targeting make a tremendous progress and gigantic era to overcome the above limitations with improved drug efficacy and reduced drug toxicity. In recent years, new strategies of surfactant coating of biodegradable polymeric nanoparticles, which differ from conventional methodologies of brain targeting, have emerged at the forefront of medical science. The non-ionic surfactant, polysorbate 80 as a coating material promises an unparalleled opportunity for enhancement of brain targeting of colloidal particles. The aim of this review is to evaluate the potential application of surfactant-coated nanoparticles as drug carrier system for various central nervous system diseases.
引用
收藏
页码:215 / 222
页数:8
相关论文
共 90 条
[1]   Blood-brain barrier structure and function and the challenges for CNS drug delivery [J].
Abbott, N. Joan .
JOURNAL OF INHERITED METABOLIC DISEASE, 2013, 36 (03) :437-449
[2]   Structure and function of the blood-brain barrier [J].
Abbott, N. Joan ;
Patabendige, Adjanie A. K. ;
Dolman, Diana E. M. ;
Yusof, Siti R. ;
Begley, David J. .
NEUROBIOLOGY OF DISEASE, 2010, 37 (01) :13-25
[3]   Carboplatin loaded protein nanoparticles exhibit improve anti-proliferative activity in retinoblastoma cells [J].
Ahmed, Farhan ;
Ali, Mohammad Javed ;
Kondapi, Anand K. .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2014, 70 :572-582
[4]   The crucial role of particle surface reactivity in respirable quartz-induced reactive oxygen/nitrogen species formation and APE/Ref-1 induction in rat lung -: art. no. 129 [J].
Albrecht, C ;
Knaapen, AM ;
Becker, A ;
Höhr, D ;
Haberzettl, P ;
van Schooten, FJ ;
Borm, PJA ;
Schins, RPF .
RESPIRATORY RESEARCH, 2005, 6 (1)
[5]   Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles [J].
Alyautdin, RN ;
Petrov, VE ;
Langer, K ;
Berthold, A ;
Kharkevich, DA ;
Kreuter, J .
PHARMACEUTICAL RESEARCH, 1997, 14 (03) :325-328
[6]  
Anderson AJ, 2011, REGEN MED, V6, P367, DOI [10.2217/RME.11.22, 10.2217/rme.11.22]
[7]   Targeted drug delivery to tumors: Myths, reality and possibility [J].
Bae, You Han ;
Park, Kinam .
JOURNAL OF CONTROLLED RELEASE, 2011, 153 (03) :198-205
[8]   Poly(n-butylcyanoacrylate) nanoparticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in Wistar rats [J].
Bagad, Mayur ;
Khan, Zaved Ahmed .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2015, 10 :3921-3935
[9]   The blood-brain barrier: an overview - Structure, regulation, and clinical implications [J].
Ballabh, P ;
Braun, A ;
Nedergaard, M .
NEUROBIOLOGY OF DISEASE, 2004, 16 (01) :1-13
[10]   Liposome application: problems and prospects [J].
Barenholz, Y .
CURRENT OPINION IN COLLOID & INTERFACE SCIENCE, 2001, 6 (01) :66-77